Pharmaceutical Approval Update.

Journal

P & T : a peer-reviewed journal for formulary management

ISSN: 1052-1372

Titre abrégé: P T

Pays: United States

ID NLM: 9015516

Informations de publication

Date de publication:
Mar 2019

Historique:

entrez: 5 3 2019

pubmed: 5 3 2019

medline: 5 3 2019

Statut: ppublish

Résumé

Inbrija (levodopa inhalation powder) for oral inhalation for the treatment of "off" episodes in Parkinson's disease; Ultomiris (ravulizumab) injection for treating adults with paroxysmal nocturnal hemoglobinuria; and Yupelri (revefenacin) inhalation solution for the maintenance treatment of patients with COPD.

Identifiants

PMID: 30828229 PMC: PMC6385732

pubmed: 30828229

pmc: PMC6385732

Types de publication

Journal Article

Langues

eng

Pagination

108-144